It has been over a year now since the approval of vilazodone (Viibryd). As you may recall from our review of the drug in TCPR April 2011, vilazodone is an SSRI with partial agonism at the 5HT1A receptor.

After reading these articles, you should be able to…

Patients are probably asking you about Deplin, or L-methylfolate, a version of folic acid that is being marketed by Pamlab as an adjunctive treatment for depression.

Nuedexta is a combination of dextromethorphan (DM) and quinidine sulfate. You might reasonably ask why these two agents would have ever been considered as a treatment for PBA.

Defining CAM is challenging. One of the things that makes it so hard to have a concrete discussion on CAM is that it means different things to different people.

Common sense dictates that genetic predispositions probably interact with life stressors to influence our mental health. Plenty of research has been published to evaluate whether this is actually true, but findings have been mixed.

Whether you see your patients quarterly, monthly, or even weekly, you certainly are not with them as much as their cell phones are.

After reading these articles, you should be able to…

Most of you have probably heard about “meaningful use” and federal incentives to get going with an electronic health record. But how applicable is this for psychiatrists? And what in the world is “meaningful use” anyway?